COMP <GO>
PETS vs WMT // GROSS PROFIT MARGIN
PetMed Express Inc. (NASDAQ) VS. Walmart Inc. (NYSE) • 15-METRIC TALLY: PETS 1
— WMT 9
▲ GROSS PROFIT MARGIN LEADER: PETS
LAST: $1.18 (-0.84%) • MKT CAP: $25.6M
gross-margins
28.10%
LAST: $121.25 (+2.09%) • MKT CAP: $961.97B
gross-margins
25.23%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PETS VS. WMT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PETS | WMT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 28.10% | 25.23% | +2.87 | PETS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 20.14% | -55.14 | WMT | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 22.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 1.39% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -32.80% | 4.39% | -37.19 | WMT | /operating-margins <GO> |
| Net Profit Margin | -32.00% | 3.00% | -35.00 | WMT | /net-margins <GO> |
| Revenue Growth (YoY) | -21.10% | 6.16% | -27.26 | WMT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.08% | 0.80% | -0.72 | WMT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.24 | 6.23 | -5.99 | WMT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 7/9 | -5.00 | WMT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.38% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 34.1 | 57.7 | -23.59 | WMT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.57 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 35.5x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $25.6M | $961.97B | -$961.94B | WMT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PETS REV | WMT REV | PETS GROSS % | WMT GROSS % | PETS FCF | WMT FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $713.16B | — | 24.9% | — | $14.92B |
| FY 2025 | $179.0M | $680.99B | 28.1% | 24.9% | -$33.0M | $12.66B |
| FY 2024 | $227.0M | $648.13B | 30.5% | 24.4% | -$395.0K | $15.12B |
| FY 2023 | $274.1M | $611.29B | — | 24.1% | $4.3M | $11.98B |
| FY 2022 | — | $572.75B | — | 25.1% | — | $11.07B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PETS // BETA —
WMT // BETA 0.57